The European Medicines Agency (EMA) today recommended adding a warning for two types of heart inflammation to Novavax’s COVID-19 vaccine, marketed under the brand names Nuvaxovid and Covovax, based on a small number of cases reported in those who received the vaccine.
Novavax COVID Vaccines Should Carry Heart Inflammation Warning, EU Says
Save
Novavax on Monday asked the World Health Organization to expand emergency use listing of its vaccine for adolescents SrideeStudio/Shutterstock
By Megan Redshaw, J.D.
Updated:
Megan Redshaw
J.D.
Megan Redshaw is an attorney and investigative journalist with a background in political science. She is also a traditional naturopath with additional certifications in nutrition and exercise science.
Author’s Selected Articles
